Does obesity affect the plasma level of Plasminogen Activator Inhibitor-1? and does CO2 pneumoperitoneum affect it?

Egyptian Journal of Anaesthesia

Volumn 29, Issue 3, 2013, Pages 203-206

  Hassanin, Abeer Ahmed Mohamed ^a   Elhusien, Amany Khairy Abo ^a   Osman, Ashraf Mohamed ^a  

^a Minia University   (Egypt)

Author keywords

CO2 insufflations; Obesity; Plasminogen activator inhibitor 1

Indexed keywords

CARBON DIOXIDE; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ADULT; ARTICLE; BLOOD LEVEL; CHOLECYSTECTOMY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYPERCOAGULABILITY; LAPAROSCOPIC SURGERY; LIGATION; LUNG VENTILATION; MALE; OBESITY; PNEUMOPERITONEUM; RISK ASSESSMENT; RISK FACTOR; STOMACH FUNDOPLICATION;

EID: 84879295347     PISSN: 11101849     EISSN: 16871804     Source Type: Journal    
DOI: 10.1016/j.egja.2013.02.007     Document Type: Article

References (16)

1. R.O. Bonow, and R.H. Eckel Diet, obesity and cardiovascular risk N Engl J Med 348 2003 2057 2059
2. D.O. Demiralp, H. Aktas, and N. Akar The effect of plasminogen activator inhibitor-1 - 675 4G/5G polymorphism on PAI-1 gene expression and adipocyte differentiation Clin Appl Thromb/Hem 14 2008 438 446
3. E. Solá, A. Vayá, F. España, R. Castelló, A. Ramón Luis, A. Hernández-Mijares, V. Vicente, and A. Estellés Plasminogen activator inhibitor-1 levels in severe and morbid obesity. Effect of weight loss and influence of 4G/5G polymorphism Thromb Res 122 2008 320 327
4. N.J. Mutch, H.M. Wilson, and N.A. Booth Plasminogen activator inhibitor-1 and haemostasis in obesity Proc Nutr Soc 60 2001 341 347
5. D. Feinbloom, and K.A. Bauer Assessment of hemostatic risk factors in predicting arterial thrombotic events Arterioscler Thromb Vasc Biol 25 2005 2043 2053
6. M. Bergström, M.L. Ivarsson, and L. Holmdahl Peritoneal response to pneumoperitoneum and laparoscopic surgery Br J Surg 89 11 2002 1465 1469
7. 2 promotes plasminogen activator inhibitor type 1 expression in human mesothelial cells Surg Endoscopy 17 2003 1818 1822
8. WHO Expert Consultation Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies The Lancet 363 2004 157 163
9. J.B. McGill, D.J. Schneider, C.L. Arfken, C.L. Lucore, and B.E. Sobel Factors responsible for impaired fibrinolysis in obese subjects and NIDDM patients Diabetes 43 1994 104 109
10. I.B. Sundell, S. Dahlgren, M. Ranby, E. Lundin, R. Stenling, and T.K. Nilsson Reduction of elevated plasminogen activator inhibitor levels during modest weight loss Fibrinolysis 3 1989 51 53
11. A.R. Folsom, H.T. Qamhieh, R.R. Wing, R.W. Jeffery, V.L. Stinson, L.H. Kuller, and K.K. Wu Impact of weight loss on plasminogen activator inhibitor (PAI-1), factor VII, and other hemostatic factors in moderately overweight adults Arterioscler Thromb 13 1993 162 169
12. P. Marckmann, S. Toubro, and A. Astrup Sustained improvement in blood lipids, coagulation, and fibrinolysis after major weight loss in obese subjects Eur J Clin Nutr 52 1998 329 333
13. A. Mavri, M. Stegnar, M. Krebs, J.T. Sentocnik, M. Geiger, and B.R. Binder Impact of adipose tissue on plasma plasminogen activator inhibitor-1 in dieting obese women Arterioscleroses Thromb Vasc Biol 19 1999 1582 1587
14. J.N. Primrose, J.A. Davies, C.R.M. Prentice, R. Hughes, and D. Johnston Reduction in factor VII, fibrinogen and plasminogen activator inhibitor-1 activity after surgical treatment of morbid obesity Thromb Haemostasis 68 1992 396 399
15. S. Matsuzaki, R. Botchorishvili, K. Jardon, E. Maleysson, M. Canis, and G. Mage Impact of intraperitoneal pressure and duration of surgery on levels of tissue plasminogen activator and plasminogen activator inhibitor-1 mRNA in peritoneal tissues during laparoscopic surgery Hum Reprod 26 2011 1073 1081
16. W.J. Brokelman, L. Holmdahl, I.M. Janssen, P. Falk, M. Bergström, J.H. Klinkenbijl, and M.M. Reijnen Decreased peritoneal tissue plasminogen activator during prolonged laparoscopic surgery J Surg Res 151 1 2009 89 93